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INTRODUCTION 
 
      Diabetes  is a common  disease   causing  lower extremity amputation 
throughout  the world,  particularly in  India, the Diabetic capital of the world1. 
By 2025, it is estimated that India will have world’s majority of diabetics.  
Diabetes Mellitus is the most important cause of non-traumatic amputations 
worldwide. Amputations are perhaps the most feared  complication of Diabetes. 
 In 2011 around 8.3% of world population had diabetes. Among these, 
vast majority were inhabiting in developing nations. It is projected that by the 
year 2030, around 10% of the human race would become diabetics. The 
troublesome fact is that this disease is being diagnosed more and more in the 
younger population of the world. Each year, over one million amputations are 
being performed to alleviate disease caused by diabetes. This roughly works out 
as one amputation in the world every 30 seconds. The predisposing factors that 
lead to amputation are diabetic neuropathy, bony deformities, inconspicuous 
trauma, and vascular diseases. In the presence of an ulcer, local sepsis and 
vascular insufficiency are major causes of amputation. The presentation of 
lesions greatly differ based on socio-economic status, quality of foot care and 
usage of footwear. It has been projected that one in six diabetics living in 
developed nations will develop ulceration before they die. This problem is even 
more menacing in developing nations. Diabetic foot not only affects the 
  
individual but also their family and the community as a whole. It causes great 
strain on the financial and health care infra-structure of the nation. Another 
cause of concern is the emergence of type 2 Diabetes in children. These cases 
will eventually progress to develop micro and macrovascular complications 
including life-threatening infections at an early age. Around 25% of these cases 
will be non-healing and upto 28% will end up in amputation. Investing in a 
scientific foot care techniques and guidelines will be more cost effective in the 
long run1.  Amputations alter quality of life and longevity.  Amputations   are 
associated with an increased risk of re-amputation  and  at an increased 
mortality in first decade after amputation. Early diagnosis and prompt therapy is 
mandatory. A team approach can reduce the number of amputations. Adequate 
infra-structure and facilities are essential. However, ignorance on the part of the 
patients and also the health care provider has made this goal hard to attain. 
 
 
 
 
 
 
 
 
 
  
AIM OF STUDY 
• To determine the various factors that are influencing major amputation in 
Diabetic foot  
• To emphasize the actions that are needed to prevent the progression of the 
disease. 
 
DESIGN OF THE STUDY 
• Descriptive Study 
 
 
PERIOD OF STUDY 
• January 2011- December   2012 
 
SELECTION OF SUBJECTS 
Inclusion Criterion 
• All cases of diabetic foot undergoing major amputation at the Department 
of General Surgery, Govt. Rajaji Hospital, Madurai during the study 
period were included in the study. 
• Major amputation is defined as below knee (transtibial) or higher levels 
of amputation.  
 
  
Exclusion Criterion 
• Patients with Diabetes Mellitus undergoing major amputation following 
trauma 
• Patients who had undergone  prior major amputation with sepsis in the 
stump 
• Patients not willing to participate in the study. 
 
CONSENT 
• Informed written consent 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
MATERIALS AND METHODS 
This study was conducted in Government Rajaji Hospital, Madurai from 
January 2011 to December 2012 and included 81 cases both males and females,  
who have been amputated in surgical ward irrespective of the age group.  
The diagnosis of Diabetes was made by measuring random blood  sugar value 
on admission. The following details were collected by a questionnaire.  
• Duration of Diabetes 
• Previous history of minor amputation 
• Whether the habit of smoking present or not 
• Educational status 
• Whether patient is using footwear or not  
• Previous history of minor amputation present or not. 
 As a protocol, patients treated in the ward with diabetic ulcer foot underwent a 
standardized evaluation for assessment of peripheral vascular disease and 
peripheral neuropathy.  
• Sensory neuropathy was evaluated with tuning fork and  Biothesiometer . 
• Nutritional assessment was done by measuring hemoglobin and serum 
albumin.  
• The diagnosis of lower extremity arterial insufficiency judged by both 
clinical and non-invasive vascular studies. 
  
o Clinical signs include clinical non-palpability of one or more 
foot pulses of the affected foot.  
o Noninvasive study included an ankle-brachial pressure index 
(ABPI) of <0.8. Abnormal noninvasive vascular study or 
suggestive clinical signs make the diagnosis of lower extremity 
vascular insufficiency 
• Wounds with frank purulence or with signs of inflammation such as 
warmth, erythema,  lymphadenopathy, edema, loss of function and pain 
were used for  the diagnosis of infection . Patients with infected wounds, 
pus culture and  sensitivity was  done. 
• To assess the renal function, blood serum creatinine values were taken. 
• To know the presence of osteomyelitis, X-ray of the local part was taken. 
• To assess the level  of major amputation, we stratified all the lower 
extremity major amputation in the following levels 
o Transtibial or below knee amputation  
o Transfemoral or above knee amputation. 
 
 
 
 
 
  
DIABETES MELLITUS-HISTORY 
Diabetes as a disease started in approximately 1550BC. Egyptian Papyrus 
records it as a disease that causes rapid weight loss and frequent urination. 
Greek physician Aretaeus of Cappodoc IA(81-133AD) described it as a disease 
in which limbs and flesh melt down meaning “a flowing through”. Galen said, 
Diabetes disease process  has an affliction to the kidneys. The term Diabetes 
was coined by Appllonius Memphites. The term Mellitus was coined by 
Thomas Willis  meaning “honey sweet” in 1675.  In1776 Dapson first 
demonstrated excretion of large amounts of sugar in urine & circulating  blood 
in diabetic patients .  The discovery of Glycogenesis in Liver is a landmark in 
history of Diabetes.  Claude Bernard said, diabetes is caused by high glucose 
synthesis, in 1800’s. During 18th  and early 19th century glycosuria has been 
accepted as a diagnostic feature of Diabetes due to metabolic derangement. In 
1869-Islets cells were discovered in pancreatic tissue by Paul Langerhans. 
Pancreas as pivotal in causation of the disease was elucidated by Mering & 
Minkowski in 1889. Discovery of Insulin and its practical application by 
Banting and Best 1921 is a major milestone. Roger Hirsworth discovered two 
types of Diabetes in 1935. In 1950, oral medications of Diabetes came into 
existence. In 1961,first injection of Insulin was developed by Decton-Dickson2. 
Various researches are going on for the treatment of Diabetes. 
 
  
 
PATHOPHYSIOLOGY OF DIABETES MELLITUS 
 
It is a metabolic disorder characterized by chronic hyperglycemia with 
generalised disturbance of metabolism. The type of Diabetes are   
• Type 1 Diabetes Mellitus ( Insulin dependent) 
• Type 2 Diabetes Mellitus (non-Insulin dependent) 
• Other specific types of Diabetes 
• Gestational Diabetes 
 
TYPE 1 DIABETES 
Constitute 10% of cases, previously termed as juvenile onset Diabetes or Insulin 
dependent Diabetes.  
• It involves complex interactions between environmental, hereditary and 
immunological entities causing damage to the  Islet cells of pancreas. 
There are two subtypes 
o Type 1 A- immune mediated characterized by autoimmune destruction of 
Beta cells. 
o Type 1 B –  It has tendency to develop ketosis but these patients are 
negative for autoimmune markers. 
• In the majority, immunological markers appears after triggering the event 
but before Diabetes become clinically evident. The immunologic markers 
  
are GAD (glutamic acid decarboxylase), IA-2/ICA-512. Assays for auto-
antibodies to GAD-65 are available commercially.  
• Although  other islet cell types  are  embryologically similar to Islet cells,  
they are not affected by immune mediated destruction. 
• Environmental factors that influence the disease process include   
viruses (eg. coxsackie and rubella), bovine milk proteins etc.        
       
TYPE 2 DIABETES 
Constitute about 80% of cases.  Previously called maturity – onset Diabetes, 
or non- Insulin dependent Diabetes of obese and non-obese type. 
• Abnormality of Insulin production and peripheral resistance are at the 
core of type 2 Diabetes Mellitus.  
• It  has genetic predisposition.There is over 90% concordance among 
monozygotic twins. Uniparental positivity increases risk of disease. 
Risk of disease is nearing 40% if biparental family history is present. 
• The disease is polygenic and multi-factorial.   
• The charecteristics of type 2 are inadequate Insulin secretion, over 
production of hepatic glucose, insulin resistence. Obesity is commonly 
seen type 2 DM.  In the early stages, glucose tolerance is retained 
inspite of Insulin resistance, due  to ability of the  islet cells to increase 
  
Insulin secretion. As the above two phenomenon progress, impaired 
glucose tolerance develops leading to overt Diabetes. 
• The metabolic abnormalities include 
1. Abnormal muscle and fat metabolism 
2. Impaired Insulin secretion 
3. Increased hepatic glucose and lipid production. 
• The METABOLIC SYNDROME  or Syndrome X  is a combination  
of Insulin resistance, systemic hypertension, Lipid abnormalities like 
hyper-triglyceridemia, truncal obesity,  impaired glucose tolerance or 
type 2 diabetes, and  cardiovascular disease. 
OTHER TYPES OF DIABETES  
• Hereditary defect of Islet cell function  
• Defective Insulin action 
• Non-Endocrine pancreatic diseases 
• Drugs or chemical induced eg. Steroids, Beta- blockers 
• Infections 
• Genetic syndromes eg. Down’s syndrome, Turner’s syndrome 
 
GESTATIONAL DIABETES 
About 4% of pregnant woman develop DM due to metabolic changes 
during pregnancy. These woman are prone to develop Diabetes in later 
life. 
  
    Hyperglycemia may result from  
• Reduced Insulin secretion 
• Decreased glucose use by the body 
• Increased glucose production 
Major stimulus for both the synthesis and release of Insulin is glucose. 
Insulin is synthesized by the Beta cells of pancreas. 
 
RISK FACTORS FOR DIABETIC FOOT ULCERATION 
 
Multiple factors are involved in causation of diabetic ulcer foot. The factors are 
• Peripheral motor neuropathy 
• Peripheral sensory neuropathy 
• Autonomic neuropathy 
• Vascular insufficiency 
• Hyperglycemic and other metabolic derangements, 
• Limited joint mobility 
• Neuro-osteopathic deformities like charcot joint 
• Patient disabilities 
• Maladaptive patient behaviors 
• Health care system failiure3 
 
 
  
 UNALTERABLE RISK FACTORS  
• Age 
• Male sex 
           The male sex has 1.6 times higher risk of ulcers.  
• Previous history of foot ulceration, presence of nephropathy, presence of  
retinopathy has increased risk of foot ulceration4. 
• Presence of limb edema hinders circulation and increases the risk of 
ulcer5. 
• Presence of callosity ( Ref image 1 ) poses increased risk. Deformities 
like prominence of the metatarsal heads, nail deformities ( Ref Image 2 ), 
clawing of the toes( Ref Image 3 ), corn foot ( Ref image 4 ), Charcot 
prominence or hallux valgus ( Ref Image 5 ) associated with increased 
risk6. 
 
ROLE OF SOCIO-ECONOMIC STATUS  
 Poor socio-economic status, assessed by literacy, earning and profession, 
is a strong predictor of amputation7,8. A lack of education means that patients 
are less likely to be aware of the importance of the prophylactic steps9. 
Treatment at primary and secondary health facilities is likely to be less often, 
the quality of care given to the low socio-economic people is more likely poor. 
This is known as ‘inverse care law’10. 
  
Quality health care and patient adherence to advice can normalize blood 
glucose levels, reduce vascular risk and normalize lipid profile. 
Frequent self inspections, foot care and proper footwear reduces the 
chances of development of foot deformities, identifying infection or injury 
earlier makes  treatment more fruitful. 
 
PRECIPITATING FACTORS 
• Physical trauma 
• Punctured wound –thorn or nail prick 
• Localized pressure from tight shoes, plastic and hard slippers 
• Repeated mechanical trauma 
• Heat 
•  Walking bare foot in hot sun 
 
 
 
 
 
 
 
 
  
 
INTERACTION OF RISK FACTORS 
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                 Neurological       Ulcer, Sepsis 
              Deficit        Deformity 
 
            Amputation 
 
 
 
 
  
PATHOPHYSIOLOGY OF DIABETIC ULCER  FOOT 
The pathophysiology of diabetic foot is due to the following factors 
• Neuropathy 
• Angiopathy 
• Mechanical stress ( Ref image 6 ) 
• Faulty wound healing 
• Metabolic derangement 
• Patient and provider’s neglect 
PATHWAY TO DIABETIC FOOT ULCERATION 
Diabetes Mellitus 
 
Somatic Sensory        Somatic Motor  Autonomic Neuropathy          PAD 
Neuropathy         Neuropathy 
 
Hypoaesthesia               Asthenia                          Hypohydrosis     Circulation Defects 
Touch 
Proprioception           Dry Skin        Dilated Veins 
  Foot Deformity           Callus     
          High Pedal Pressure 
 
                       FOOT AT RISK 
                 Repeated Injury 
FOOT ULCER 
 
  
DIABETIC NEUROPATHY 
Polyneuropathy is one of the commonest complications of Diabetes .Most 
common among neuropathies in patients with diabetes  are chronic sensori-
motor distal symmetric polyneuropathy and the autonomic neuropathies. 
Sensory deficit starts in the lower limb distally and progresses to involve feet 
and legs in a ‘stocking’ pattern. This is followed by the upper extremeties in a 
‘glove’ like pattern. Diabetes affects autonomic nervous system also. As the 
disease progresses wasting of the small muscles of the hand and  asthenia of the 
limb occurs. Sensory loss is the main clinical symptom. Some patient may 
experience tingling, burning  pain , shooting pain down the legs. Neuropathic 
pain is nocturnal and causes insomnia11. They may develop postural 
hypotension, depressive symptoms 12. A paradoxical feature is that both pain 
and numbness may co-exist in the same limb, a phenomenon aptly named as 
‘painful, painless’ leg13. The former is due to C fibre damage and the latter due 
to A fiber damage14.The commonest clinical presentation is reduced sense of 
vibration in the toes. Ankle jerk is absent and with advancement of disease knee 
reflex also gets involved. Capillary circulation is an important component, the 
alteration of which, can lead to neuropathy. Vasa Vasorum involvement hinders 
the clearance of metabolic end products from the tissue and also prevents 
nutrient delivery, thereby producing nerve damage 18. Autonomic neuropathy 
leads to hypohidrosis and predisposes to breakage of dry skin5.The 
  
‘purely’neuropathic foot is actually warm because of abnormal A-V shunting 
16,17
.This abnormal increase in blood flow can lead to neuropathic oedema. The 
American Diabetologist Association recommends screening for neuropathy ,at 
the time of diagnosis and for autonomic neuropathy five years after initial 
diagnosis in Type 1 and at the time of diagnosis in Type 2 Diabetes followed by 
annual screening thereafter. 
       Diabetic polyradiculopathy is a neurological manifestation characterized by 
disabling pain along the course of one or more nerve roots. Truncal 
radiculopathy causes pain over the thorax and abdomen. Involvement of the 
lumbar plexus  or femoral nerve may cause severe pain in the thigh or hip and 
have diabetic amyotrophy.  All these are usually self-limiting and resolve over 
6-12 months. 
Mononeuropathy is less frequently seen compared to polyneuropathy. It 
presents with pain and paresis along the distribution of a particular nerve. 
Involvement of Occulomotor Nerve is most common, heralded by diplopia. 
Examination shows ptosis, opthalmoplegia with normal pupil reaction to light.  
4th , 6th and 7th cranial nerves  may be affected.  Peripheral mononeuropathies 
with concomitant affliction of more than one nerves may occur. 
  
       Autonomic neuropathy can involve multiple systems. Cardiovasular 
effects include tachycardia at rest and orthostatic hypotension. Gastroparesis 
and bladder voiding abnormalities may be seen. Diabetic cystopathy is the  
  
inability to sense bladder fullness and failure to empty the bladder completely. 
It can cause impotence and sexual dysfunction in both male and female.  
Increased sweating of the upper extremities and anhydrosis of the lower 
extremities may occur. Anhydrosis leads drying and crackling of feet which 
increases chances of ulcer formation. Peripheral neuropathy plays a key role in 
the events leading on to amputation.  
 
PROPOSED HYPOTHESIS OF DIABETIC NEUROLOGICAL 
DAMAGE 
• Nerve Ischaemia 
• Protein kinase c activation 
• Free radical injury 
• Metabolic pathway hyperactivity eg. Polyol pathway 
• Nerve Regeneration abnormalities 
• Chronic High circulating glucose levels 
 
CHARCOT FOOT ( Ref Image 7 ) 
 
Charcot  neuroarthropathy is manifested by joint dislocations without 
major trauma and pathological fractures19.It is of idiopathic origin. The concept 
by Virchow states that bony changes were due to unperceived sub-clinical 
trauma that are usually not noticed due to insensitivity of the joint. There is 
  
reduced bone density in the foot in patients with Charcot neuropathy. The 
earliest clinical manifestation is swelling of the foot with pain or discomfort. 
The study  by Boykao et al, found relationship between ulcer and charcot 
deformity, but other foot deformities were not independent ulcer predictors20.  
Acute Charcot foot may be mistaken for gout, cellulitis, and osteomyelitis21. 
Plain radiographs will show bone and joint destruction and loose bodies. Three 
phase   99mTc bisphosphonate demonstrates active Charcot process. The 
treatment given  to Charcot foot patients are prolonged immobilization using 
total contact cast, (Ref Fig 8) Charcot restraint orthotic walker(CROW), 
Schotchcast boot(SCB),and Pneumatic walking braces. 
ANGIOPATHY 
Diabetes can affect both macro and microcirculation. In patients with 
Diabetes, atherosclerosis develops at an early age. Medial calcification, Diffuse 
intimal fibrosis and Atherosclerosis are the most common macrovascular 
changes observed with Diabetes. The most common  risk factors associated to 
vascular component are  dyslipidemia,  hypertension, duration of Diabetes, 
severity of the disease, smoking, Insulin resistance. Moss and colleagues said  
that current smokers less than 30 years of age were more prone to ulcerate22.  
Cessation of smoking  is associated with a decrease  the atherogenic process. 
Hypertension is almost twice common in diabetics compared to non-diabetics. 
 
  
Arteriosclerosis, specific diabetic microangiopathy  and diabetic 
fibrillosis are the micro vascular changes observed with Diabetes. The typical 
histological changes  are thickening of capillary basement membrane,  
proliferative changes in arterioles and arteries which include enlargement and 
proliferation of endothelial cells.  Enlargement of endothelial cell  is a feature in  
diabetes leading to small vessel occlusion, causing  foot ulceration23  termed  
‘small vessel disease’ with  the presence of  palpable  pulses in the foot. 
Increased resting blood flow due to  denervated sympathetics causing loss of 
vasoconstriction, with  loss of regulation in circulation in the  arterio-venous 
vessels. A ‘capillary steal’ phenomenon is induced leading to shunting of blood 
away from the capillaries leading to reduced skin nutrition. This explains 
paradoxical ulceration despite increased blood flow. 
 
PERIPHERAL VASCULAR DISEASE 
Peripheral vascular disease occurs at an early age in diabetic patients . It 
is highly likely to involve vessels below popliteal artery. The mechanism by 
which vascular disease causing lesion of nerves are ischemia caused by 
occlusion of vessels, altered permeability of capillaries causing osmotic and 
metabolic derangements.  In western countries,  vascular alterations is an 
important  factor for foot ulcerations causing major  amputations later 24.  Minor 
trauma and antecedent infections increase blood requirement beyond the 
capacity, leading to ischemia and ulceration. Patients presents with intermittent 
  
claudication, rest pain and nocturnal pain. Nocturnal pain and rest pain are 
relieved by keeping legs in dependent position. The circulation is predominantly 
caters to the splanchnic area during sleep, resulting in decreased perfusion of 
the lower extremities resulting in ischemic neuritis that disturbs sleep. The 
features of the ischemic limb are cold feet with absent pulses, delayed venous 
filling with blanching on elevation. There is loss of hair, thickened nails, and the 
skin appears shiny.  Clinical assessment of the peripheral circulation is 
extremely useful in the assessment of outcome25. 
 
FAULTY WOUND HEALING 
 
• Due to prolonged persistence of the abscess 
• Poor  granuloma formation 
• Presence of bullae, necrobiosis 
• Fungal infection of the nail 
• High rate of carriage of staph.aureus in the nares 
 
METABOLIC DERANGEMENT 
 
Hyperglycemia in diabetics impair the complement fixation, ketosis 
impairs the leukocyte function, monocyte mediated immune functions are  
diminished, and alteration in polymorphonuclear  leucocyte function leading to 
  
deficient wound healing. Abnormal glucose levels and toxic metabolites play a 
role.. 
HAEMATOLOGY 
Plasma viscosity, Platelet activity, Haemotocrit , red cells and white 
blood  cells deformability  are altered in diabetic patients. These changes 
profoundly influence the ischaemic process. 
INFECTION 
 Infections in the foot are common with diabetics.  Uncontrolled infection 
may progress to  amputation26. Even with advancement in the treatment,  
uncontrolled sepsis  cause about 60% of the lower extremity amputation 27,28. In 
patients with gangrene due to diabetes  amputations is the treatment29. Moist 
gangrene is most common in diabetic patients.  Diabetic patients  without 
infection, the prognosis is better than patients with infection. If the  bones are 
involved,  the risk of  amputation is around eight times than those with 
involvement of soft tissue  alone30. Fungal infections are common in the web 
space in the diabetics. Infections may occur in the nailbed. Preventing cross 
infection influences the outcome. 
  
 The descriptions  of the involved  region is by  
• Severity 
• Extent of the involvement ( Ref  image 9) 
• Clinical appearance 
  
• Location 
• Etiology 
 
There are two categories: 
• Non-limb threatening 
• Limb threatening 
• Extensive infections that threaten limb or life require prompt 
hospitalization and appropriate treatment. 
 
Foot infections occur at the site of trauma or ulceration1. If there is a 
breach in the epidermis, colonisation of the bacteria occur in the dermis and the 
underlying tissues. Usually the inflammatory signs are absent around the 
wound.  They may present with symptoms like fever, nausea, and fatigue. They 
may present with unexplained increase in the blood sugar levels. If these  
features are found, sepsis should be suspected.   
 The lesions should be thoroughly examined to rule out exposed bones, 
joints and tendon sheaths. Failing to do so will result in rapid progression and 
involvement of deeper structures. The spread through tendon sheaths  occurs 
both proximally and distally.  Gold standard for diagnosing ulcer with infection 
is punch or tissue biopsy since the culture of the wound are often misleading 
and may not represent the organism within the underlying granulation tissue. 
The severity of the infections are assessed by 
  
• analyzing depth of the wound, 
•  presence of ischemia,  
•  the presence of infection 
In the presence of osteomyelitis, bone sampling and sensitivity testing become 
minimum required procedures to prevent progression to more aggressive stages 
of the disease. 
 
FOOT ULCER DEFINITION & CLASSIFICATIONS OF DIABETIC 
FOOT 
The International consensus currently defines a “ foot ulcer” in the diabetic 
patients  as a “full-thickness wound below the ankle , irrespective of the 
duration” 31. 
 
Classifications: 
The International Working Group On Diabetic Foot recommends use of a 
uniform classification system to 
• Enable universal understanding among health care providers 
• Provide accurate assessement of healing potential 
• Standardize management protocols 
• Eliminate observer variations 
• Should be universally acceptable and usable32. 
  
Universally used classification is WAGNER’S CLASSIFICATION33 
Diabetics possess a life time risk of around 15% for possible ulcer 
formation34. 
WAGNER CLASSIFICATION36 
Grade 0 - No ulcer but high risk foot ( deformity or cellulitis) 
1- superficial diabetic ulcer  
2 - ulcer extends to ligaments, tendons, joints, capsule or deep fascia  
     without abscess and /or osteomyelitis 
3 – deep ulcer with abscess/ osteomyelitis/ joint sepsis 
4 - gangrene localized to portion of fore foot  
5 - extensive gangrenous involvement of entire foot 
 
This  most valuable grading  for the diabetic ulcer foot designed by 
William Wagner. It is also known as WAGNER-MEGITT’S 
CLASSIFICATION. This system help to analyze the progress of the patient, 
both positive and negative outcomes, and  to standardize the treatment plan. 
CLASSIFICATION – UNIVERSITY OF TEXAS38 
Aetiology (Stage) included - 
Stages 
–Stage A: No infection or ischemia 
–Stage B: Infection present 
  
–Stage C: Ischaemia present 
–Stage D: Infection and ischaemia present. 
Grading 
–Grade 0: Epithelialized wound 
–Grade 1: Superficial wound 
–Grade 2: Wound penetrates to tendon or capsule 
–Grade 3: Wound penetrates to bone or joint 
 
The other classification is SAD system, which adds to the Texas system the 
cross-sectional area and the presence of neuropathy or not 35. 
The ‘PEDIS’ system includes  
• Perfusion (ischaemia) 
• Extent 
• Depth 
• Infection 
• Sensation (neuropathy) 
  
More recently, International Working Group on Diabetic Foot ( IWGDF ) has 
created a classification that grades  wound size ,perfusion of foot, the presence 
of infection, and the presence of  sensation.The flaw in all classifications is that 
none of these systems considers the duration of the foot ulcer37, which has great 
bearing on healing 38. 
  
ASSESSMENT OF DIABETIC ULCER FOOT 
Proper assessment of diabetic foot involves adequate history, clinical 
examination and investigations. 
 
HISTORY 
 
•  MEDICAL HISTORY 
1. Diabetes – Duration 
2. Treatment history 
3. Co-morbidities 
3. Nutrition 
4. Addictions 
5. Current drug intake 
6. Hypersensitivities 
7. Past Medical or surgical history 
• GENERAL HISTORY 
1. Everyday activities 
2. Foot Protection 
3. Callus formation 
4. Bony deformities of the foot 
5. Neuropathic symptoms 
6. Claudication or rest pain 
  
• WOUND/ ULCER HISTORY 
1. Area involved 
2. Number of months involved 
3. Precipitating cause 
4. Previous involvement in the same site 
5. Infection 
6. Hospitalization 
7. Wound care 
8. Wound healing 
9. Patient adherence to advice 
10. Social problems hampering adequate wound care 
11. Previous foot trauma or surgery 
12. Presence of  pedal edema 
13. Charcot arthroneuropathy 
 
EXAMINATION 
 
1. skin changes 
2. sweating 
3. infection:  clinical assessment is useful. One should look for 
• The discharge whether serous or purulent,  
• soft tissue involvement 
  
• presence of temperature 
• pus culture and sensitivity  
4.   bony changes 
5. Deformities of the foot 
6.  wasting of small muscle 
7.Surface temperature of skin 
 
LABORATORY TESTS 
This includes fasting or random glucose measurement, glycosylated 
haemoglobin, complete blood count,  C - reactive protein, and urinalysis. 
 
Neurological assessment 
• Tuning fork assessment of vibration sense  
• C-Fibre assessment by pinprick.  
• 10-g monofilament to assess the foot ulcer risk status39, a semi-
quantitative measure of light touch40,41. ( Ref Image 10 ) 
• Light touch assessment by using cotton wisp 
 
Vascular assessment 
• Peripheral pedal pulses  should be palpated 
• Doppler ultrasound probe evaluation 
  
• Ankle-Brachial index. An ankle pressure of less than 70 mm hg leads to 
poor healing of ulcers; if it is more than 100mm Hg, the prognosis is 
good. 
• Transcutaneous oxygen tension ,a noninvasive test of circulation in the 
periphery. 
• Skin blood flow calculated from Xenon 133 clearance. 
•  Segmental arterial pressures, waveform analysis by using Doppler 
 
INDICES OF POOR WOUND HEALING 
If the  ankle-brachial index of less than 0.8,  the measured toe blood pressures 
less than 40 mmHg, or the level of  transcutaneous oxygen tension (TcPo2)  less 
than 30 mmHg are associated with poor healing of the wound. If these 
parameters are present, vascular surgeon consultation becomes essential.  
 
Quantitative sensory testing 
Vibration assessment 
Biothesiometer, ( Ref Image 11 )   Neurothesiometer –handheld device to assess 
vibration perception. It is portable and easy to use in an out-patient setting. 
Detection of diminished vibration sense is a predictor of impending ulceration 
42
. 
 
 
  
Temperature assessment 
A portable instrument Neuroquick 43, useful for testing  cold sensation, and for 
screening  early neuropathy. 
 
Infection assessment  
By doing pus culture  and sensitivity. It is often misleading, not represent the 
organism underlying the granulation tissue. “ Gold standard”  test is punch or 
tissue biopsy. 
 
Repetitive Moderate stress assessment  
Thermography- Patients with insensitive feet shows hyperemic thermographic 
pattern. 
“In-shoe”  foot prints helps to detect the area of maximum stress. 
 
Osteopathy assessment 
To confirm the suspected cases of the bone involvement imaging studies are 
usually done. It is also useful to plan the  correct treatment for the affected foot.  
Plain X-rays 
 Relatively cheap, quick, widely available. It is the first  imaging 
modality for patients with  suspected bone infection. It takes two weeks for the 
changes to be seen in the plain x-ray. In plain x-ray, presence of calcified 
vessels, gas, foreign body, osteolytic changes, fractures, dislocations in  
  
neuropathic arthropathy, biomechanical  alterations  and osteomyelitic changes 
can be seen. The osteomyelitic  changes are focal osteopenia, cortical erosion, 
and periosteal reaction, soft tissue swelling and permeative  radiolucency . It is 
very difficult to differentiate aseptic neuroarthropathy  by means of plain x-ray 
from suspected osteomyelitis. Even if the initial images on plain x-rays are not 
contributory to the diagnosis of  suspected  osteomyelitis,  regular radiologic 
imges  should be done.  
 
Direct Digital Radiography markedly reduces the effect of radiographic 
overexposure. Routine views are dorsi-plantar and oblique views. Specialized 
views are lateral view, standing  view without support,  seasomoids, forefoot, 
subtalar, heel and ankle views. Currently weight bearing dynamic views are 
recommended. 
 
LIMITATIONS OF RADIOGRAPHY 
 
•  Difficult to assess the soft tissue involvement 
•  Due to the presence of overlying structures, not accurately measures 
bony involvement 
•  Only around the bony edges, cortical bone involvement is made out 
 
 
  
 
MAGNATIC RESONANCE IMAGING 
 It  is the  best modality to  delineate infection and neuropathy with its precision 
reaching almost 100%. Presence of   fluid in the soft tissue can be made out. To 
know the extent of involvement, this modality is most useful43. 
 
ANATOMY OF THE SOLE OF THE FOOT 
SKIN 
It is thick , firmly attached  to the deep fascia by  fibrous bands. sweat 
glands are present in large numbers. The sensory nerve supply to the medial  
skin of sole  is derived from the tibial nerve, lateral part  of the sole is 
innervated by corresponding  plantar nerve,and its Medial two thirds  is 
innervated by medial plantar nerve. 
DEEP FASCIA 
         Deep treasure metatarsal ligaments and aponeurosis together constitute 
deep fascia. Flexor retinaculam  extends from the Medial malleolus  to the 
medial surface of calcaneum. It attaches the tendons of deep muscles to the 
medially in the  ankle. The  aponeurosis  occupies the central area of Sole, 
triangular in shape and its  apex is attached to the  calcaneum,  and its  base  
attached to  the toes. Each slip has two bands, passing superficially to the skin 
and  deeply to the root of toe. Fibrous septa  form the  fascial spaces of sole, 
  
gives  firm attachment to the overlying skin. It  protects  the underlying vessels, 
tendons,  nerves. It helps to maintain the arches in the foot. 
MUSCLES OF THE SOLE 
They are divided into four layers. 
I Layer       Abductor hallusis 
                   Abductor digiti minimi 
                   Flexor digitorum brevis 
                
II Layer     Lumbricals 
                   Flexor hallucis longus  
                   Flexor digitorum longus  
                    
III Layer   Flexor hallusis brevis 
                   Flexor digiti minimi brevis 
                   Adductor hallusis 
                   
IV Layer   Interossei 
                  Tibialis posterior  
        Peroneus longus 
 
 
 
  
ARTERIAL SUPPLY 
1.Medial Plantar Artery  
Medial side of toe is supplied by it, gives off numerous cutaneous, muscular  
and articular branches. 
2.Lateral Plantar Artery 
Plantar arch is supplied by it.  Plantar arch gives  digital arteries to lateral side 
of the small toe and both sides of four  lateral toes. 
3.Dorsalis Pedis Artery(DPA) 
 DPA  joins with the  plantar artery on the lateral aspect  and supplies plantar 
arch . 
Its branches are 
-Lateral tarsal artery 
-First dorsal metatarsal artery which supplies both side of big toe. 
-Arcuate artery supplies metatarsal branches to the toes. 
Medial and lateral plantar veins accompany the corresponding arteries and join  
behind the medial malleolus to form the posterior tibial venae commitanes. 
 
 
 
  
NERVE SUPPLY 
1. Lateral Plantar Nerve 
Supplies flexor digit minimi, abductor hallucis, quadaratus, plantaris, abductor 
digiti minimi,second and third and fourth  lumbricals  and all interossei.It  
supplies  cutaneous twigs to the skin sole on lateral aspect,  one and half toes on 
the lateral aspect,and its nail beds and tips. 
2.Medial Plantar Nerve 
supplies muscular branches to abductor hallusis, flexor hallusis brevis,flexor 
digitorum brevis. It also supplies cutaneous branches to medial three and  half 
toes and its corresponding nail beds and tips. 
 
 DORSUM OF THE FOOT 
SKIN 
 Skin on the dorsal aspect  is  freely mobile on the underlying tendons and 
bones. Sensory nerve supply to the dorsum is derived from the superficial 
peroneal nerve. It also receives sensory innervations by deep 
peroneal,saphenous, sural nerves.The skin covering the dorsal surfaces of 
terminal phalanges, nail beds are supplied by medial and lateral plantar nerves. 
 
Knowledge of the spaces of the foot is very important because infections in any  
of the spaces result in extension along fascia or tendon. The four medial spaces 
can be approached from inside of the foot by an incision along  inner  border of 
  
first metatarsal bone. The digital vessels arise from dorsal arch pass via 
intermetatarsal ligaments to the toes. Infection of the toe or web space if not 
adequately controlled spreads deeper. It reaches the tendon sheaths of long 
flexors or lumbricals and spread to 3rd layer. Very high pressure build up in the 
closed area because of pus, edema, and presence of gas forming organisms. This 
causes tissue necrosis and mechanical pressure on digital vessels leads to 
gangrene of the foot. 
 
ANATOMY OF THE LEG 
Superficial  fascia  
Contains superficial veins like great saphenous vein, short saphenous vein, 
cutaneous nerves like infrapatellar branch of saphenous nerve, saphenous 
nerve,lateral cutaneous nerve of calf, superficial peroneal nerve, sural nerve, 
lymphatics, and small unnamed arteries. 
Deep fascia 
Extension of deep fascia form the septa divide the leg into three compartments 
anterior, posterior and lateral. 
Anterior compartment 
Muscles 
Tibialis anterior 
Extensor hallucis longus 
  
Extensor digitorum longus 
Peroneus tertius 
Vessels       Anterior Tibial vessels 
Nerve         Deep peroneal nerve 
 
Lateral Compartment 
Muscles 
Peroneus longus 
Peroneus brevis 
Nerve         Superficial peroneal nerve 
Vessels       Peroneal vessels 
 
MEDIAL SIDE OF THE LEG 
Formed by medial surface of the shaft of tibia. The greater part of this surface  
is subcutaneous and is covered by skin and superficial fascia. Three muscles are 
inserted into the upper part of medial  surface of the tibia from three 
compartments of the thigh namely Sartorius, gracilis, and semitendinosus 
forming Guy ropes. 
 
 
 
 
  
BACK  OF THE LEG 
Superficial fascia of the back  of the leg contains small and great 
saphenous veins and their tributaries, several cutaneous nerves,and medial and 
lateral calcaneal arteries.  
Superficial muscles  of this area are   
• Gastronemius  
• Soleus   
• Plantaris 
Nerve supply to superficial  muscles of the back is Tibial nerve. 
 Posterior group of muscles that are present in deep aspect are   
• Popliteus 
• Flexor digitorum longus 
• Flexor hallucis longus 
• Tibialis posterior  
 Vascular  supply to this area by Posterior tibial vessels.  
 
ANATOMY OF THE THIGH 
FRONT OF THE THIGH  
The superficial fascia of the front of the thigh contains great saphenous vein, 
cutaneous nerves, vessels, lymphatics and lymph nodes.The upper third of the 
  
thigh medially contains the femoral triangle, middle third  carries the femoral 
vessels through the adductor canal. Muscles of the frontal aspect of the thigh are 
Sartorius 
• Rectus femoris 
• Vastus lateralis 
• Vastus intermedius  
• Vastus medialis 
Nerve supply :  Femoral Nerve 
 
MEDIAL ASPECT OF THE THIGH 
Muscles  
Adductor longus 
Adductor brevis 
Adductor magnus 
Gracilis 
Pectineus 
Obturator externus 
Nerve supply 
Obturator nerve 
Accessory obturator nerve 
  
Arterial supply 
Obturator artery 
Medial circumflex  femoral artery 
 
BACK OF THE THIGH 
Muscles  
Semitendinosus 
Semimembranosus 
Biceps femoris 
Nerve supply  Sciatic nerve 
Vascular supply 
 Lateral circumflex femoral 
 Medial circumflex femoral vessels 
 
BIOMECHANICS OF FOOT 
Biomechanics is a science that deals with effect of forces acting on living 
tissues. The major cause of ulcer formation in diabetics is loss of pain 
sensitivity.44 Most of the non-healing ulcers are not caused by super-added 
medical conditions, but due to presence of basic biomechanical factors. 
Progressive elevation of  plantar pressure is a reliable predictor of ulcer 
formation45,46.Biomechanical factors play pivotal role in all phases of 
  
management of foot ulcers starting from prevention level to tertiary expert care 
level. 
 
STRESS AND STRESS CONCENTRATION 
The mean pressure acting at the feet of a 100kg individual is about 75 
kilopascals. Dynamic pressures are higher compared to static pressures and 
simple walking47.Shearing stress also has a key part in the evolution of ulcers. 
 
NEUROPATHY AND HIGH PRESSURE ( Ref image 12 ) 
Peripheral neuropathy results in loss of sensations that confer protection 
against injury. This loss is severe enough that patients may not even perceive 
severe trauma such as penetrating injury to the feet or even scalding caused by 
boiling water or burns. Disuse atrophy predisposes to ulceration. High pressure 
areas that frequently ulcerate include toes and head of metatarsals50,51. Pressure 
applied repeatedly over the same areas especially those overlying bony 
prominences in the setting of profound sensory loss causes ulcer formation that 
starts from within out ie, from bone to the outer soft tissue.48. Callus are often 
found on inspection.  They have a dark base indicative of an underlying deep 
ulcer which bleeds and stains the deep surface of the callus49. 
INTRINSIC FACTORS CAUSING ELEVATED PRESSURE 
• Changes in foot architecture like long second metatarsal  
  
• Increased angle of foot arches 
• Soft tissue lesions like callus, clawing of toes due to fat pad migration 
leaving bony prominences exposed 
• Limited joint mobility 
 
EXTRINSIC FACTORS CAUSING ELEVATED PRESSURE 
• Poor foot wear 
• Ill fitting shoes 
• Non compliant soles 
• Prior surgery 
ACTIVITIES CAUSING ELEVATED PRESSURE 
• Bare foot walking 
• Improper shoes 
• Improper foot care 
• Altered gait 
 
MANAGEMENT OF DIABETIC FOOT 
The primary target of diabetic foot management is wound closure as early 
as possible. Enabling quick healing of ulcers and preventing reoccurrence 
reduces the need for amputations.  
The essential avenues of diabetic foot management are: 
  
• Control of co-morbidities 
• Ensuring adequate vascularity 
• Assessing  psychosocial factors 
• Ulcer apparaisal 
• Ulcer bed preparation 
• Relieving pressure 
Treatment differs according to the nature of the wound. It can be either 
‘conservative’ therapy or surgical intervention. Before planning for surgical 
intervention care should be given in the form of antibiotics, adequate care of the 
foot. Debridement of wound should be given. If necessary offloading  
techniques may be used for the wound to heal.  Patient should be advised to 
maintain good glycaemic control. All the devitalized tissues should be removed. 
If there is involvement of the bone, it should be removed. If there is presence of 
pus, incision and through drainage should be done. These prompt measures may 
provide healing of the wound.  
 
PAIN MANAGEMENT IN DIABETIC NEUROPATHY 
Management components include 
• Control of blood glucose levels 
• Reduction of Cardiac risk factors. This encompasses control of blood 
pressure, Body mass index, Hypercholesterolemia and tobacco use.52 
  
• Tricyclic anti-depressnats like Amitryptilin and SSRI group of drugs like 
Duloxetine are primarily used53. These drugs in their corresponding doses 
used have a safe side effect chances54. 
• Anticonvulsants are useful in the treatment of pain due to neurological 
involvement. The drugs commonly used are barbiturates  and 
carbamazepine. The recent therapies are gabapentin55, pregabalin56. These 
new drugs provide pain relief better than the previously used drugs. 
• Opioid derivatives-   These derivatives are useful in relieving neuralgia57. 
• Topical capsaicin- These act via reduction in levels of Substance P. The 
draw back is that there may be an initial increase in pain before drug 
effect takes action58. 
• Alpha-lipoic acid Infusion - 600 mg per day for 3-weeks is helpful in 
neuropathic pain59.  
• Isosorbide Dinitrate Spray and Glyceryl Trinitrate Patch- 
• Nitrate spray60 and patch61 applications lead to improvement of 
neuropathic pain. 
•  Non-pharmacological treatments 
1. Acupuncture 
2. Near-infrared therapy 
3. Low-intensity laser therapy62 
4. Transcutaneous electrical stimulation 
  
5. Direct stimulation of the spinal cord by surgical implants 
6. Frequency modulated electromagnetic neural stimulation63. 
 
MANAGEMENT OF PERIPHERAL VASCULAR DISEASE 
Before planning for surgical intervention in the form of either bypass or 
angioplasty ,it should be analysed whether this procedure will actually benefit 
the patient, the outcome of the planned surgery,  and complications associated 
with the planned surgery either immediate and long term. If the vascular 
surgeon is competent to do the endovascular surgeries, this form  of treatment 
is preferred because of minimum morbidity and in the expert hands this is very 
safe procedure. 
 
Indications for Angioplasty: 
• Short stenoses 
• Aorto-illiacs dilatable 
• Life expectancy less than 2 years 
• Occlusions less than 20cm 
• Ulceration due to Venous causes 
• ABPI > 0.5 
 
Indications for surgical bypass: 
  
• Femoral Artery block 
• Advanced ischaemic necrosis 
• ABPI < 0.5 
• Life expectancy > 2 years 
• Combined inflow and CFA disease 
Absolute indications for surgery: 
• Unsuccessful angioplasty 
• Rutherford Class II ischaemia 
• Aneurysms 
• Extensive calcification 
 
When the above options are not available or if the patients are not affordable to 
these procedures then palliative approach is the best option. Amputations are 
usually done for these patients. Rehabilitative measures should be given for 
these patients. 
 
TREATMENT OF DIABETIC FOOT INFECTIONS 
Treatment of diabetic foot infections are divided  into non-limb threatening and 
threatening infections.  
 
  
 
Non-limb threatening infections 
To define, these are medically stable patients having no signs of systemic 
sepsis. They are ideal candidates for outpatient management under close 
supervision. 
Clinically, these group of patients have superficial ulcers with minimal 
ischaemia and lack bone or joint involvement. Cellulitis is confined to within 
2cm of the ulcer margins. Many of these cases are monomicrobial with 
staphylococcus aureus, staphylococcus epidermiditis and beta hemolytic 
streptococci being the most common ones to be isolated.  Samples for cultures 
are acquired by curettage of the infected ulcer.  Oral antibiotic therapy is 
initially given. MRSA should be covered under the spectrum. The ulcer should 
be debrided as often as necessary. 
 
Limb-threatening  infections 
This group includes 
• Cellulitis beyond 2cm of ulcer margin 
• lymphangitis 
• Ischemic Tissue necrosis 
• Odour 
• Gangrene 
  
• Bone involvement 
These patients require emergent hospital admission and appropriate 
intervention. The patient’s co-morbidities should be evaluated. Extent of 
infection should be thoroughly assessed.  A team approach in treatment 
improves outcomes. 
Initial management by a surgeon includes debridement, drainage of toxic fluid 
or pus, decompression by fasciotomy or limited amputations to curtail progress 
of infection. During this, wide range of culture specimens should be obtained to 
identify bacteria and fungal growth. Sub-Arachnoid Blocks should be avoided 
in these patients. 
The presence of hemodynamic imbalance or profound systemic compromise 
should not deter the surgeon from taking up debridement. Only clearance of 
infected tissue will improve the internal milieu of the patient. Most of such 
cases have poly-microbial infections requiring intravenous antibiotics initially 
rather than oral medication. Osteomyelitis should be evaluated radiologically 
and microbiologically. Debridement of the infected bone and even minor 
amputations may be needed. Bone cement containing antibiotics are available 
for use after adequate debridement, provided adequate soft tissue cover is 
availabe.  
 
 
 
  
DRESSINGS 
Dressings are done to keep the wound clean and free. It removes excess 
bacteria from the wound. It removes excess fluid. Materials used should not 
cause toxicity to the wound. It should be non-adhesive.  Various types are  
1. Honey dressing- provides moisture, decreases odour, reduce 
inflammation,  reduce oedema and exudates. 
2. Silver-containing dressings- Silver is having  broad spectrum of activity. 
It kills  yeast, fungi, viruses and methicillin and vancomycin strains64. 
3. Iodine-Dressings. 
4. Hydrocolloid Dressings- Create moist healing  environment, should not 
be used in heavily infected wound 
5. Alginate dressings- Derived from sea weed, have the capacity to absorb 
large amounts of exudates. 
6. Hydrogels- Promote autolytic wound debridement in dry wounds, absorb 
exudates in moist wounds. 
7. Hyalofill- Derivative of hyaluronic acid, should be used on clean wounds. 
8. Living skin equivalents- Dermagraft or graftskin. 
 
LARVAL THERAPY 
Maggots are living chemical factories. Worms remove dead tissues by the 
production of a mixture of proteolytic enzymes that breakdown dead tissue to a 
  
semi-liquid form ingested by creatures, stimulate fibroblast growth in vitro, 
eliminate odour and reduce wound related pain.  
 
GROWTH FACTORS 
Growth factors play a key role, regulating all aspects of wound healing. 
Epidermal growth factor(EGF), fibroblast growth factor 2 (FGF-2) and platelet 
derived growth factor(PDGF) all have been approved in the treatment of 
diabetic foot ulcers. 
 
OFFLOADING THERAPY 
The choice of technique is based on the physical form and compliance 
with the treatment, and also site and severity of the ulcer. The aim is to reduce 
dynamic foot pressure74.  
Total contact cast (TCC)  is  gold standard in management. Total contact 
cast should not be used in patients with local sepsis and vascular compromise. 
Other options are Removable cast walkers, Charcot restraint orthotic walkers, 
Healing sandals and half shoes, felted foam padded dressings, therapeutic shoes 
and insoles. 
This line of management should be continued till there is complete 
healing of ulcers. 
 
  
SURGICAL INTERVENTION 
It is often indicated for deep infection or for the treatment of recurrent or 
recalcitrant ulceration. They include debridement of recalcitrant or infected 
ulcers, drainage and debridement of soft tissue infection,bone resection for 
relief of pressure and or for osteomyelitis; closer techniques; Achilles 
lengthening surgery; and reconstruction of forefoot deformities. Primary or 
delayed closure is advocated as more effective, much more cost-efficient and 
successful. Low pressure or vacuum assisted closure is particularly valuable 
when there is insufficient soft tissue surplus to allow for primary closure of the 
wound edges. 
DEBRIDEMENT 
Debridement serves several purposes: 
• Excision of dead tissues and callus. 
• Pressure alleviation 
• Ulcer bed assessment 
• Probing of tracks and tunnels  
• Decreasing microbiological load 
There are Five types of debridement 
• Surgical 
• Enzymatic 
• Autolytic 
  
• Mechanical 
• Biological 
Early surgical intervention by debridement has been demonstrated to be 
the best. 
 
SURGICAL DEBRIDEMENT 
 Aggressive removal of the devitalized tissues is done by sharp scissors 
and scalpels. Extent of debridement should be sufficient enough to reach all 
margins of infection both in the deeper plane and also in the horizontal plane. 
The aim of this approach is to convert a chronic non-healing wound into an 
actively bleeding acute wound that will have the capacity to granulate and 
regenerate. Deep seated abscess mandates hospitalisation and immediate 
incision and drainage. Removal of bones either locally or by limited 
amputations may be necessary. Repeated removal of necrotic tissue expedites 
rate of healing. This is known as as “maintenance debridement”. 
 
 
Hydro surgery 
     Its properties are 
• Precise and 
• Limited Excision 
• Negligible thermal damage to the tissues. 
  
An extremely painful  wound may benefit from enzymatic debridement. 
Vascular wounds are candidates for enzymatic debridement. 
 
MOISTURE BALANCE 
Moisture accelerates re-epithelization in a wound. Tissue moisture is a 
term used to convey the importance of keeping wounds moist and free of excess 
fluids. A moist wound environment promotes granulation and autolytic 
processes. Effective management of chronic wound fluids is an essential part of 
wound bed preparation. It also helps in addressing the issues of cellular 
dysfunction and biochemical imbalance. 
ADVANCES IN WOUND CARE 
Preparation of ulcer bed enables removing barriers which hinder healing 
and to start the healing process. Advanced care sometimes becomes the only 
means of attaining wound closure. The discovery of recombinant growth 
factors, genetic manipulation, artificial tissues, stem cell therapy have 
empowered the surgeon and wound-care provider to aid in angiogenesis to 
accelerate healing. 
 
VAC THERAPY 
Delivery  of intermittent or continuous sub-atmospheric pressure through 
a specialized  pump connected to open-celled foam surface dressing covered 
  
with an adhesive drape to maintain a closed environment. It increses blood 
flow, decreases local tissue edema, removes excessive fluid and pro-
inflammatory    exudates from the wound bed65,66. 
 
AMPUTATIONS 
Amputations, an unpleasant but often final end result of the diabetic foot. 
It  is performed for multiple reasons and can be either curative or emergent. 
Amputation level selection aims at achieving balance between preservation of 
limb length and function with the ability of the wound to heal properly. 
Currently available vascular surgical advances have made ‘limb sparing’ 
more and more feasible. Endovascular restoration of vascularity have made it 
possible to do more distal amputations. Pre amputation vascular intervention 
must be done to limit level of amputation and also to facilitate proper stump 
healing. 
 
AIM OF DECIDING LEVEL OF AMPUTATION 
• To leave behind a stump that can readily accept prosthetic shoe, orthotic 
device or complete limb prosthesis 
• To create a stump that is less likely to breakdown from external pressures 
• To prevent dynamic imbalances that may occur due to migration of digits 
such as in migration of the other digits after 1st MTP joint disarticulation, 
  
varus deformity that occurs due to lateral loading of the foot following 5th 
Toe Ray amputation. 
• To facilitate primary wound healing so as to enable rapid healing of the 
stump and early rehabilitation of the amputee. 
If infections are not controlled or due to the advancement in the disease 
process, diabetics usually succumb to lower extremity amputation. The 
incidence of amputations for non-traumatic etiologies is ten times higher in 
Diabetes67,68. Costs of amputation and its descendent managements are very 
high69 This is due to length of hospitalization that is required and due to 
multiple investigations and repeated surgical and vascular interventions that 
may be required. 
Various amputations of lower extremity are 
•  Ray’s amputation 
•  transmetatarsal (Gillies)  
• tarsometatarsal (lisfranc’s)  
• midtarsal(chopart’s)  
• syme’s  
• Below-knee(Burgess)  
•  Transcondylar  
• above-knee 
 
  
The three most common indications for major lower extremity 
amputations are  
• acute limb ischaemia 
• chronic critical limb ischaemia 
•  major infection due to malperforans ulcers in diabetics with normal 
arterial circulation. 
GOALS 
The goals of major lower extremity amputations are : 
•  to eliminate the nonviable tissue 
•  to provide a stump with best chance to heal 
•  to provide a stump with best chance of long term function-ambulation 
with prosthesis. 
IDEAL STUMP 
• The ideal stump should heal adequately 
• should have rounded ,gentle contour with adequate muscle padding 
• should have adequate length to bear prosthesis 
• should have thin scar which does not interfere with prosthetic function 
• should have adequate joint movement 
• should have adequate blood supply. 
 
 
  
GENERAL PRINCIPLES APPLICABLE TO AMPUTATION SURGERY 
SKIN 
Flaps should be sutured in a tension free manner and the  scar should be 
well healed and non-adherent to the bone.  
MUSCLE 
Myodesis should be performed to facilitate balanced action of opposing  
muscle groups. 
NERVE 
Neuroma formation should be prevented by dividing the nerve at a higher 
level by applying adequate traction and allowing it to retract into the stump 
under cover of muscles. Nerves should never be ligated. 
 
BLOOD VESSELS 
Visible bleeding alone does not indicate optimum level of amputation.70 
Wound healing in reality is dependent on micro-circulation. Vessels must be 
suture ligated, arteries and veins in separate group to avoid iatrogenic AV 
fistula formation. 
BONES 
Bone should be cut at a higher level and ends beveled so as to avoid 
protruding bone that will interfere with healing of stump and also result in a 
painful end bearing stump. 
  
STUMP DRESSINGS 
A cotton wool followed by crepe bandage is commonly used dressing for 
the amputation stump. A rigid cast support 71 enables wound protection, 
contracture prevention and  oedema reduction. 
 
TYPES OF AMPUTATION 
RAY amputation 
Amputation of the toe with the head of metatarsal or metacarpals. 
 
TRANSMETATARSAL AMPUTATION (GILLIES’) 
Amputation is done proximal to the neck of the metatarsals, distal to the base. 
 
LISFRANC’S AMPUTATION (TARSOMETATARSAL) 
Here tarsometatarsal joint is disarticulated with a long volar flap. 
CHOPART’S   AMPUTATION (MIDTARSAL) 
Here talonavicular and calcaneocuboid joints are disarticulated. Tibialis 
anterior  is sutured to the drilled talus bone. A long volar flap is used and 
immobilized for six weeks after surgery. 
 
 
SYME’S AMPUTATION 
It is removal of the foot with calcaneum and cutting tibia and fibula just 
above the ankle joint with retaining heel flap (dividing both malleoli).Heel flap 
  
is supplied by medial  and lateral calcaneal vessels . Elephant boot is used for 
the limb after syme’s amputation. Many patients walk well with syme’s stump 
without difficulty. It is presently mainly used in trauma(crush injuries) and 
malignancies of the distal part of the foot.  
 
PIROGOFF’S AMPUTATION 
It is like syme’s amputation except the posterior part of the calcaneum is 
retained along with heel flap. It provides longer stump than syme’s amputation. 
TRANSTIBIAL(BELOW-KNEE) AMPUTATION ( Ref image 13 ) 
Knee joint is spared. The ideal stump is 15cms long  
The advantages of preserving the knee joint are  
• lower kinetic energy requirement  
• near normal gait  
• Ease of using prosthesis 
• Self Sufficiency and reduced dependancy  
• Quicker rehabilitation  
• Less expensive prosthesis 
 
 
 
 
  
KNEE DISARTICULATION(THROUGH-KNEE) AMPUTATION 
It is through the joint and does not disturb the bone. It is used in patients 
with poor general condition and those who are not amenable to prosthetic 
mobilization 
 
TRANSFEMORAL(ABOVE-KNEE) AMPUTATION (Ref image 14 ) 
About 12-15cm of lower end of  femur should be removed. Usually equal 
anterior and posterior flaps are used. If femur length less than 10cms this 
procedure is not possible. If femur length is less than 10 cms, then should 
proceed with hip disarticulation. The marked reduction in limb length 
drastically reduces propulsive power and manipulation of the prosthesis. 
Efficient ambulation depends solely on the user’s ability to mobilize the 
artificial knee joint in the prosthesis. 
 
CURATIVE VERSUS EMERGENT SURGERY 
Performance of amputation in the elective setting may not always be a 
possibility. When serious infections such as gas gangrene are starting to set in, it 
becomes mandatory to perform an emergency amputation. Before surgical 
intervention, pre-existing infection should be dealt with. Elective amputations 
are usually curative ie, primary wound healing is facilitated by raising flaps and 
closing the wound primarily. Emergency amputations aim at removal of 
  
necrotic tissue only and not at healing the stump primarily. Subsequent surgery 
may be required to close the wound once the infection has been controlled. 
COMPLICATIONS OF AMPUTATION SURGERY 
Early complications: 
• Hemorrhage 
• Infection 
• Haematoma 
Late complications: 
•  Pain  
• Flap necrosis 
• Ring sequestrum formation 
• Ulceration of the stump  
• Painful scar 
• Phantom limb 
 
POSTOPERATIVE PERIOD AFTER AMPUTATION 
•  Regular physiotherapy  
•  Regular dressing  
•  Crutch is used initially 
•  After 3 months prosthesis is  used 
•  Rehabilitation 
  
 
PROBLEMS IN AMPUTEES IN DIABETICS 
Fluid overload caused by cardiac failure or renal diseases in diabetics 
may cause fluctuation in the volume of the stump. This provides challenges in 
proper fitting and maintainance of prosthesis.  
 
FOOT WEAR  & DIABETES 
The state of art in footwear prescription for patients with Diabetes is still 
rudimentary. Narrow shoes, pressure from footwear, inadequate foot wear, 
trauma from foot wear, barefoot walking,  are widely believed to cause many 
foot injuries and even amputations in persons with Diabetes. 
Therapeutic foot wear works by 
• Accomodating the bony deformity 
• Adequate space for allowing use of thick special insoles etc. 
• Dynamic load reduction 
• Load transference from risk areas   
• Forcing the patient to acquire a proper gait and stance 
• Providing pads to off-load the metatarsals 
• Providing medial longitudinal arch support  
  
• Newly detected diabetic patients should be educated  about the need for 
appropriate foot wear. 
•  For diabetic patients who is at risk for an ulcer should use extra-depth 
shoes72 
• Delayed institution can cause reulceration 
• For patients with a recently healed ulcer should be given well-
cushioned walking splint or orthopedic walker so that fragile tissue can 
heal  
• Graduated use of the new foot wear should be advocated 
•  For charcot patient, patellar tendon bearing brace to transfer some of 
the load to the leg.  
 
 
 
 
 
 
 
 
 
  
OBSERVATIONS AND RESULTS 
 
Risk factors associated with MAJOR amputation in diabetic foot 
1) AGE 
 
Table1: Table showing age distribution of study subjects 
 
 
 
 
 
 
 
 
 
 
Amputations were more common in the 50-70 year age group. 
 
 
 
 
 
Age group (years) Number of subjects 
20-30 4 
30-40 6 
40-50 10 
50-60 26 
60-70 20 
70-80 12 
80-90 3 
TOTAL 81 
  
 
2) SEX 
Table 2: Among the study subjects, 48(59.5%) were male and 33(40.5%) 
were female. 
Sex Number of subjects 
Male 48 
Female 33 
Total 81 
 
Amputations were more common males compared to females. 
3) DURATION OF DIABETES MELLITUS 
TABLE3: Table showing duration of Diabetes Mellitus in the study subjects 
DURATION OF DIABETES  Number of subjects 
<5YEARS 11 
6-10 YEARS 25 
11-20 YEARS 31 
>20 YEARS 14 
TOTAL 81 
 
The actual duration of Diabetes Mellitus may be underestimated due to 
delay in diagnosis. 
  
 
4)Previous history of minor amputation 
         Table showing previous history of minor amputation of study subjects 
Previous history of minor amputation 
 
Number of subjects 
Nil 42 
Toe disarticulation 14 
Ray amputation 18 
Mid tarsal/Tarso metatarsal 5 
Syme’s Amputaion 2 
TOTAL 81 
 
Those who underwent previous minor amputation of the lower extremity 
are more prone for major amputation of the lower extremity. 
 
 
 
 
 
  
 
5) Educational Status 
Majority  of the subjects had primary school education or less.  
   Table showing educational status of study subjects 
Educational Status 
 
Number of subjects 
Illiterate 14 
Primary school 48 
Higher Secondary 13 
Degree or higher 6 
TOTAL 81 
 
6) Use of footwear 
Use of Foot wear Number of subjects 
Yes 53 
No  28 
TOTAL 81 
 
Among the study subjects 53 (65.4%) were in the habit of using footwear 
while 28 (34.6%) were not. 
  
7)Smoking 
Smoker Number of subjects 
Yes 34 
No  47 
TOTAL 81 
 
34(42%) of the study subjects were smokers while 47( 58%) were non 
smokers 
 
8) Arterial insufficiency in the affected limb 
The arterial status of the affected limb was assessed by recording the 
Ankle brachial index. 
ABPI Number of subjects 
<0.3 12 
0.4-0.8 32 
>0.9 27 
TOTAL 71 
 
Ankle brachial pressure could be measured in only 71 of the 81 patients prior 
to the amputation. 
  
9) Neuropathy 
Neuropathy Number of subjects 
Present 62 
Absent 19 
TOTAL 81 
 
The presence of neuropathy was assessed by Tuning fork testing and 
biothesiometry. 
Among the subjects studied 62(76.5%) had neuropathy while 19(23.5%) did 
not have neuropathy. 
 
10) Anemia 
Hemoglobin (g/dl) Number of subjects 
<8 39 
8-12 28 
>12 14 
TOTAL 81 
67 (82%) of the 81 patients studied had a haemoglobin level of <12 gm%  
 
 
  
11) RBS value on admission 
RBS (mg/dl) Number of subjects 
<110 12 
110-140 17 
140-200 7 
>200 45 
TOTAL 81 
45 (55.55%) of the subjects had RBS value more than 200 mg% on admission. 
 
12) Renal function test 
Sr.Creatinine (mg/dl) Number of subjects 
<1.0 57 
>1.0 24 
TOTAL 81 
 
      24(29.6%) out of the 81 subjects had  elevated renal function test ( S.     
      creatinine>1.0 mg/dl) 
 
 
 
 
  
 
13) Serum albumin levels 
S. Albumin(g/dl) Number of subjects 
>3.0 13 
2-3 45 
<2 23 
TOTAL 81 
 
 
14) Presence of osteomyelitis 
Osteomyelitic changes  Number of subjects 
Present 29 
Absent 52 
TOTAL 81 
 
Among the study subjects 29(35.8%) had evidence of osteomyelitis on imaging. 
 
 
 
 
 
  
 
 
15) Pus culture and sensitivity 
MICROORGANISM Number of subjects 
Proteus vulgaris 9 
Escherichia coli 15 
Pseudomonas aeruginosa 18 
Staphyococcus aureus 13 
Polymicrobial 26 
TOTAL 81 
 
Polymicrobial infections were the most common among the study subjects. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
DISCUSSION 
     The studies by Most RS et al 75, Siitonen OI et al 76, Armstrong DJ et al 77, 
Group TG 78, have shown increasing age and male gender are unavoidable risk 
factors for amputation. In our study amputations were more common in the 
Fifth  and sixth decade and there is a male preponderance of 1.46:1. 
 Kumar 79, Walters 80  have found that increasing duration of the diabetes is a 
risk factor for amputation. In our study,  majority of the patients had long 
duration of diabetes. 
 Studies by Litzelman et al 81 , Kumar et al , Carrington et al, Boyko et al, 
Abbott et al, Kastenbauer et al, have found previous history of amputation  is a 
risk factor for amputation. In our study, 44.4% of subjects has a previous  
history of minor amputation. 
 In our study, 76.5%  had primary schooling or lesser education. This is quite 
low compared to western studies.  If the educational status is low, they are 
usually unaware of  preventive steps to be taken. Attendance of health care 
facilities is likely to be less frequent( Adams AS et al 82 ). 
 Studies by ChantelauE et al 83  have found  the use of footwear in diabetes 
mellitus prevents the development of the initial ulcer and prevents recurrence of 
ulcer at the same site or different site. In our study, 34.6% of subjects did not 
even use the foot wear at all.  
  
Studies by Moss and colleagues84  found smokers of younger age were more 
likely to ulcerate in diabetic patients. In Wisconsin study 84, there was a 
borderline significance between smoking and ulceration in diabetic patients. In 
our study,  42% of study subjects were smokers. 
 In our study 54.3%  had arterial insufficiency. This is  in accordance with 
studies by Walters et al 79 , Kumar et al 80 , Boyko et al and Abbott et al. 
Studies by Walters 79, Litzelman , Kumar 80, Carrington , Abbott et al, Boyko 85, 
Kastenbauer  have found neuropathy is a risk factor for amputation in diabetic 
ulcer. In our study 76.5% of subjects had neuropathy detected by tuning fork 
test and Biothesiometer. 
Studies by Carrington et al 86 ,  show that strict glycaemic control can prevent 
amputation in diabetic foot. In our study, 55.55% of subjects had a  blood 
glucose level of more than 200mg/dl. 
Fernando DJS et al 87, have found  diabetic nephropathy is a factor for foot 
ulceration sometimes progresses to amputation. In our study, 29.6% had 
diabetic nephropathy. 
 Serum albumin level more than 3gms% is necessary for adequate wound 
healing to occur (Dickhaut SC et al 88). In our study, 83.9% of subjects had a 
serum albumin level  less than 3gms%. 
 Osteomyelitis can present with the failure of the local part to heal. If there is 
extensive soft tissue loss, bone may be infected.   Usually bone is infected by 
the way of blood spread. Whereas in diabetic patients , bone involvement occurs 
  
due to infection spread form without inwards ie, from the overlying soft tissue 
to the deeper bone (Berendt AR89, Lipsky BA90  et al ). In our study 35.8% of 
subjects had evidence of osteomyelitic changes on imaging. 
Studies by Lipsky BA et al , Borrero E , Goldstein EJ, Viswanathan V 91 et al 
shows that staphylococcus aureus is the most important pathogen followed by 
coagulase negative staphylococcus. With optimal microbiological techniques , 
most of these infections are noted to be polymicrobial. In our study, 32.09% of 
subjects had polymicrobial  infection, and 16.09% of subjects had infection with 
staphylococcus aureus. However, studies by Cunha BA 92 et al, have found 
organisms like enterococci, and pseudomonas aeruginosa, are often colonizers 
rather than pathogen, and antimicrobial therapy specifically targeted against 
them may not be required. 
 
 
 
 
 
 
 
 
 
 
  
STEPS TOWARDS PREVENTION 
                  The high prevalence of foot infections and the subsequent economic 
burden on an already strained economy, gives rise to urgent need to promote 
foot care in a country like India. The essential step in this goal is early diagnosis 
of loss protective sensation and ischemia. Surface  examination of the foot to 
diagnose deformities, skin involvement is essential . Toe-nail should be 
properly taken care of. Injuries caused by toe nails, nail infections and 
onychocryptosis should be identified. 
 
                 Life-long care regarding the type of foot wear used should be 
exercised. The aim of footwear is prevention of ulcer formation, prevent re-
ulceration and new site ulcer formation. Nearly 80% of the patients can be 
benefited from ‘over-the-counter’ sport shoes with custom-made insoles. Only 
patients with severe deformities require custom-molded shoes. The 
biomechanical goal is load reduction and weight transference. 
                Foot before ulcer formation requires meticulous and scientific care by 
self and also by the clinician. The management team members include  
• Podiatrist 
• Internist 
• Ophthalmologist 
• Endocrinologist 
  
• Infectious disease specialist 
• Cardiologist 
• Nephrologists 
• Vascular surgeon 
• Orthopedic surgeon 
• Nurse ( educator, wound care, and home care) 
• Pedorthist/orthotist. 
                   Frequent education of patients and family members is essential. 
This includes knowledge regarding glycaemic control, diet plans , proper foot 
wear  and need for early identification of early foot lesions. Primary, Secondary 
and tertiary levels of care are required to be imparted into the patients 
knowledge so as not to burden the clinician alone with the sole responsibility of 
care of the patient. Health care personnel education is equally important. A 
recent study from Chennai reported that of 1259 patients  at previous high risk 
and who presented with foot ulcers, healing occurred in 82% who were judged 
to have adhered to foot ulcer care advice, compared  to 50% of those who did 
not73. Patients should be given ample advice on glycaemic control, smoking 
reduction, regular exercise, dietary pattern changes, use of low-dose aspirin and 
statin therapy. 
                    The Himalayan psychosocial and economic costs of Diabetes foot 
diseases can be brought down by simple preventive measures. Though it may 
  
not be possible to completely prevent ulceration, it is definitely possible to 
prevent progression of small lesions to the level of amputation.  
 
The KEY elements of preventive care are : 
• Yearly examination by health care providers to determine risk factors 
• Examination of at-risk feet at each visit 
• Patient awareness on daily foot care and diabetes management 
• Establishment of specialized clinics to concentrate exclusively on 
diabetic patients 
60% of patients with ulcer will have recurrence of ulcer in the same 
region. Despite wide-spread availability of newer therapeutics and 
diagnostics, the effective prevention of reulceration is paramount in 
reducing the social and economic burden caused by diabetic foot 
ulcers.Therapeutic foot wear plays a key role in this context. The 
Achilles heel in attaining this elusive target still remains the patients lack 
of knowledge and non-compliance with advice of expert health-care 
personnel.   
 
 
 
 
 
  
 
CONCLUSION 
 
• The majority of the amputees in our  study were males. The 
number of the cases being 48 males and 33 females. This workout 
to a preponderance ratio of 1.46: 1. 
• Amputations  were more commonly done in the age group of 50 to 
60 years. Rehabilitation of these patient subset proves to be a 
difficult task given the occurrence of numerous other co-
morbidities such  as hypertension, coronary heart disease and 
neurological disorders etc. 
• There seems to be apparent reduction in the rate of amputation in 
the older age groups. This observation cannot be projected with 
certainty because of the fact that these older  age group subjects do 
not present to the hospital in most cases,and also they are less 
prone to ulceration due to the generalized decrease in the 
ambulatory capacity. 
• Longer the patient with diabetes,  the more chance of landing up 
with amputation.  In our study , 45 out of 81 patients underwent 
major amputation , having diabetes for more than 10 years 
duration. 
• In our  study, 36 out of 81 patients had previous history of minor 
amputations. 
  
• 65.4% of our study subjects who were infact using footwear, still  
ended up with ulcerations leading to major amputation. This is  
mostly due to lack of knowledge regarding proper and adequate 
foot care. 
•  A  vast majority of our study subjects had peripheral neuropathy 
(76.5%) as a risk factor for amputation, rather than chronic arterial 
insufficiency (54.3%). 
• 68 out of 81 cases had profound malnutrition, indicated by serum 
albumin level of less than 3 gms. Improvement of the nutritional 
status helps to overcome sepsis and promote wound healing. 
• Majority of the infections in diabetic ulcers were polymicrobial 
followed closely by the presence of Pseudomonas aeroginosa.  
• Osteomyelitis in a diabetic foot is very difficult to treat and 
frequently necessitates amputation. Among the study subjects 
29(35.8%) had evidence of osteomyelitis on imaging. 
 
Amputation often becomes a palliative or life saving procedure. Major 
amputations in the younger age group has devastating socioeconomic 
consequences. Advances in prosthesis and rehabilitation can lessen this 
burden. Still the most cost effective methods are directed at prevention. 
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IMAGE 1:  CALLUS 
 
IMAGE 2 : NAIL DEFORMITY 
 
 
  
 
 
IMAGE 3: CLAW TOES 
 
IMAGE 4:  CORN FOOT 
 
  
 
 
 
 
 
IMAGE 5: HALLUX VALGUS 
 
 
 
 
 
 
  
 
 
 
 
 
IMAGE 6 : PRESSURE POINTS 
 
 
 
 
 
  
 
 
IMAGE 7: CHARCOT FOOT WITH ULCER 
 
 
IMAGE 8: TOTAL CONTACT CAST 
 
  
 
 
IMAGE 9: EXTENSIVE ULCER 
 
 
ULCER INVOLVING FOOT & ANKLE 
  
 
 
 
IMAGE 10: MONOFILAMENT TEST 
  
 
IMAGE 11: BIOTHESIOMETER  
 
 
 
  
IMAGE 12: NEUROPATHIC ULCER 
 
 
 
 
 
 
IMAGE 13: BELOW KNEE STUMP 
  
 
IMAGE 14: ABOVE KNEE STUMP 
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PROFORMA 
 
HISTORY: 
1. Age 
2. Sex 
3. Duration of Diabetes Mellitus 
4. Educational  Status 
5. Smoking Habit 
6. Foot Wear Use 
7. Previous H/O minor Amputation 
 
CLINICAL EXAMINATION: 
1. Peripheral Pulses 
2. Site of the ulcer 
3. Extent of the Leison 
4. Ankle Brachial Pressure Index 
5. Neuropathy assessment (Tuning fork / Biothesiometer ) 
6. Foot deformities 
 
 
INVESTIGATIONS: 
  
1. Random Blood Sugar 
2. Hb% 
3. Serum Creatinine 
4. Serum Albumin 
5. Swabs  from all foot lesions for C&S 
6. X-ray of the local part. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
KEY TO MASTER CHART 
 
History of previous amputation: 
• A: Nil 
• B: Toe disarticulation 
• C: Ray amputation 
• D: Mid tarsal amputation 
• E : Syme’s amputation 
Literacy 
• A: illiterate 
• B: Primary School 
• C: Higher Secondary 
• D: Degree 
Pus culture and sensitivity 
• A: Proteus mirabilis 
• B: E. coli 
• C: Pseudomonas aeroginosa 
• D: Staphylococcus aureus 
• E: Polymicrobial infection 
Foot wear 
  
• Y-  Yes 
• N-  No 
Smoking 
• Y -  Yes 
• N  - No 
Neuropathy 
•  Y -  Yes 
•  N  - No 
Osteomyelitis 
• Y – Yes 
•  N - No 
 
 
 
 
 
 
 
 
 
MASTER CHART
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
A B C D E F G H I J K L M N O P Q R
Pus
C&S
1 JEYABALAN 56 M 43910 16 A B Y Y 1 Y 12 132 0.8 2.4 N B
2 NARMATHA 42 F 47194 2 C B N Y 0.7 Y 8 240 1.6 1.6 Y E
3 JEYALAKSHMI 24 F 55178 4 E D Y Y N 13 138 0.7 2.5 N C
4 MURUGESWARI 61 F 32188 21 A A Y Y 1 Y 9 96 0.9 2.8 Y E
5 GAJENDRAN 57 M 37666 13 C B N Y Y 14 134 2 2 N B
6 KARUTHAMMAL 66 F 36899 24 E A Y N 1 Y 7 128 0.9 1.6 N C
7 JESUDOSS 59 M 48777 16 C B Y Y 0.8 Y 10.4 121 0.8 2.6 N E
8 KANAGALAKSHMI 56 F 56544 5 D B Y N 1 Y 9 234 1.8 2.6 N B
9 RAMANATHAN 22 M 38769 5 A D N N 0.5 Y 12.4 259 0.7 1.8 N A
10 DEIVANAYAGAM 67 M 52314 5 C A Y Y 1 N 6 89 1.4 2.3 N E
11 PANDI 44 M 47689 4 D B Y N 0.6 Y 11 234 0.9 1.7 Y C
12 RATHINAM 34 F 39936 3 D C N N 1 N 6 320 2.6 2.6 N A
13 MURUGESAN 54 M 41707 13 A B Y Y 0.7 Y 13 180 0.9 1.8 N E
14THANGAPANDIAMMAL64 F 41124 25 B B N N Y 11.6 240 3 2.4 N A
15 JOSEMIN 25 F 45677 5 A D Y N 0.5 Y 9 79 0.8 2.8 N B
16 KATTURAJA 57 M 41723 14 A B Y Y 0.4 Y 11 214 2.4 2.2 N C
17 BUVANESWARI 33 F 46990 5 C B Y N 0.9 Y 8 245 0.7 1.5 Y D
18 KARUPPASAMY 51 M 53266 11 B B N N 0.7 Y 10.8 83 0.6 1.8 Y B
19 KUTHAPERUMAL 46 M 62788 8 A B Y Y 1 Y 7 234 0.8 2.1 N D
20 CHINNAIAH 68 M 35666 22 D A Y Y 0.8 Y 12.8 256 2.6 1.9 N C
21 NELAMEGUM 58 M 53838 13 B B N Y 1 Y 9 115 0.9 1.6 Y A
22 SUBBULAKSHMI 45 F 53255 8 A B Y N 0.9 Y 11.4 235 3.2 2.2 N C
23 MARY 36 F 60113 4 C C N N Y 12.2 154 0.9 2.3 N B
24 ADAIKAN 56 M 61866 13 B B Y Y 0.7 Y 8 94 0.9 2.6 Y D
25 SOUNDRAPANDI 64 M 70829 26 A B N N 1 Y 7 244 0.8 1.8 N E
26 THASNEEM 56 F 65790 11 B B Y N 0.9 Y 7 86 1 2.2 N C
27 SUMATHI 43 F 72761 6 A C Y N 1 N 11 208 0.8 1.7 Y E
28 SUBRAMANIAN 64 M 45688 16 B B Y Y 0.8 Y 6 78 0.8 2.6 N B
Hb RBS Creatinine S. Alb OsteomyNeuropathyNo. Name Age Sex IP n0. Yrs Prev ampu Literacy* Footwear Smoke ABPI
MASTER CHART
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
A B C D E F G H I J K L M N O P Q R
29 KAMAL MUSTAFAH 57 M 70825 17 B B Y Y 1 Y 12.4 289 1.8 3.2 Y E
30 PANDIAMMAL 68 F 67899 9 A B Y N 0.5 N 7 267 0.7 3.3 N A
31 NAGAPPAN 67 M 27287 16 B B N Y 0.7 Y 7 74 0.9 2.7 N E
32 MUNIYAMMAL 61 F 32284 15 A B N N 0.5 Y 12.8 119 0.9 1.5 Y B
33 VERAN 39 M 37375 7 A C Y N 0.9 N 8 224 1 3.2 N E
34 ARPUTHAM 56 M 36845 9 B B N Y 0.6 N 13 168 0.8 2.7 N C
35 NATARAJ 48 M 43454 8 A C Y Y Y 7 280 1.4 3.1 N E
36 KARUPPAYEE 67 F 35467 5 B B N N 0.9 N 10 267 0.7 2.6 Y D
37 MUNIARAJ 71 M 66789 25 A A Y N 0.8 Y 13 254 1 1.8 Y E
38 BHAGAVATHY 54 M 56781 6 A B Y Y 0.6 N 9 174 0.9 2.4 N C
39 RAMANATHAN 67 M 43910 13 A B Y Y 0.6 Y 10.6 278 1 2.8 Y E
40 GANAGALAKSHMI 44 F 59917 8 A B Y N 0.9 N 8 84 0.8 2.4 N B
41 NAGAMMAL 57 F 61609 17 B B N N 0.8 Y 11.4 288 1.6 3.2 N E
42 KANAGARAJ 59 M 63697 15 A B Y N Y 7 256 0.9 2.4 Y C
43 RAJAMEGAM 68 M 73561 14 B B N Y 1 Y 9 180 1.8 1.9 Y E
44 UMA 49 F 76369 7 A C N N 0.4 Y 11 280 1 2.3 N A
45 MAJID SULTAN 36 M 36857 13 C D Y Y 0.8 Y 10.4 118 1.4 3.1 Y E
46 SUJATHA 29 F 55609 7 A D N N 0.2 N 7 280 0.9 2.5 N C
47 THIRUMALAI 58 M 89076 8 B B Y N 0.5 N 9 240 0.9 1.6 Y E
48 JOHN 58 M 56789 8 B B N Y 0.3 Y 10.4 260 0.8 2.9 N D
49 GOMATHI 49 F 45543 6 A B Y N 0.6 N 8 124 1.6 3.2 N B
50 SUNDARAM 54 M 15560 13 B B Y Y Y 11.4 280 0.7 2.8 Y E
51 SAROJA 54 F 35609 8 A C Y N 0.7 N 7 250 0.8 3.1 N A
52 RAMAR 69 M 10922 16 A B N Y 0.3 Y 11.4 240 0.9 2.6 N E
53 AROCIAMARY 65 F 16534 8 B B Y N 0.9 Y 11 180 0.8 1.8 Y D
54 NAGAPPAN 48 M 16476 8 A B N Y 0.6 N 10.2 226 2.2 2.5 N A
55 SUBRAMANIAN 56 M 16494 15 A C Y N 0.2 Y 9 240 0.7 3.2 Y E
56 RATHNAVEL 74 M 19480 14 A A Y N 0.3 Y 9 229 2.2 2.7 N B
57 PANDIAN 68 M 29875 16 B B Y Y 0.8 Y 8 114 0.8 3.3 Y E
58 CHITRA 31 F 29887 9 A D Y N 0.9 Y 10 236 2.4 2.4 Y D
MASTER CHART
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
A B C D E F G H I J K L M N O P Q R
59 KALEEL IBRAHIM 75 M 46578 23 B A N Y 0.3 Y 11.8 108 0.9 1.9 N E
60 KASTURI 59 F 68795 7 A C N N 0.9 N 7 240 1.8 2.3 N B
61 JEYABALAN 69 M 45612 8 A B Y Y Y 11 260 1 1.6 Y C
62 POTHUMPONNU 79 F 32789 25 A A N N 0.9 Y 7 250 0.8 2 N D
63 MUNUSAMY 69 M 25879 6 C B Y Y 0.6 Y 10.8 290 2.4 2.6 Y B
64 RAMAMOORTHY 61 M 43143 7 B B Y N 0.1 Y 7 120 0.9 3.2 N D
65 VEDAMMAL 57 F 51889 8 A C Y N N 10.8 260 1.1 2.8 N C
66 KARUPANAN 77 M 77954 26 A A Y Y 0.7 Y 14 233 1 2.8 N B
67 PANCHU 73 F 78017 29 A A Y N 0.9 Y 11.4 246 1 1.8 Y E
68 PRABHU 71 M 53458 28 A B Y Y 0.2 Y 9 272 0.9 2.6 Y C
69 SUNDARAJAN 56 M 42365 15 A C N N 0.7 Y 7 128 0.9 2.1 N D
70 GANESAN 76 M 15759 14 A B Y N 0.9 Y 13 116 0.9 1.9 N E
71 MANIKANDAN 86 M 65241 25 B A N Y 0.3 Y 12 132 0.7 3.4 N C
72 PANDIAMMAL 75 F 28030 29 A A Y N 1 N 8 136 1.5 2.8 Y B
73 ASHOKAN 83 M 34150 15 B A Y N 0.6 Y 6 88 0.9 1.6 N A
74 LAKSHMI 55 F 43100 8 A C N N 0.2 Y 12.4 124 0.6 2.6 N D
75 RUKMANI 73 F 43663 30 B A Y N Y 10.4 114 1 3.2 Y E
76 SEKAR 53 M 44953 9 A C Y Y 0.7 N 8 160 0.7 2.4 N C
77 JEYALAKSHMI 83 F 50284 16 A B Y N 0.3 Y 12.8 289 0.8 1.8 N D
78 SRINIVASAN 57 M 28097 14 B B N N 0.7 Y 8 240 1.6 2.6 N C
79 SIVAKUMAR 71 M 79394 16 A B Y N Y 7 78 0.9 1.9 N E
80 PANDI 78 M 82527 15 B B Y N 0.6 Y 11 220 0.8 3.1 Y C
81 RAJEENABEGUM 56 F 73427 11 D B N N 0.9 Y 10.2 240 2 2.1 N D
